SCHEMBL2840963

SCHEMBL2840963

Cc1cc2c(s1)CN(C)CCC2Oc1cccc(Cl)c1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.35
GPBAR1 Q8TDU6 5/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTR1D P28221 2/20 0.32
HTR1B P28222 2/20 0.32
DRD2 P14416 2/20 0.32
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32
HTR6 P50406 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2840393 0.99 SIGMAR1 (0.35) SIGMAR1GPBAR1MAPTHTTRECQL
SCHEMBL2844218 0.89 UTS2R (0.30) DRD1DRD5SSTR1SSTR4
Hydrochloric Acid SCHEMBL2875741 0.88 KDM4E (0.32) SIGMAR1ALDH1A1SMN1; SMN2DRD2HTR7
SCHEMBL2837016 0.84 DRD1 (0.38) SIGMAR1GPBAR1MAPTALDH1A1GAA
Hydrochloric Acid SCHEMBL2879094 0.83 DRD1 (0.38) SIGMAR1GPBAR1MAPTALDH1A1GAA
SCHEMBL2840628 0.82 HCRTR1 (0.36) KMT2AL3MBTL1HTR1ASLC6A2SLC6A4
SCHEMBL2837859 0.82 SSTR1 (0.36) MAPTALDH1A1KMT2ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL2841547 0.81 MEN1 (0.37) KMT2AL3MBTL1HTR1ASLC6A2SLC6A4
SCHEMBL2838989 0.80 FPR2 (0.37) SIGMAR1ALDH1A1SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL2840923 0.79 UTS2R (0.31) DRD1DRD5SSTR1SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US claimed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP claimed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 SIGMAR1 25/4885GPBAR1 141/4885MAPT 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.